Twist Bioscience (TWST) Depreciation & Amortization (CF) (2017 - 2026)

Twist Bioscience (TWST) has reported Depreciation & Amortization (CF) for 10 consecutive years, with $6.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) changed 0.19% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $24.7 million (down 11.04% YoY), while the FY2025 annual figure was $24.9 million, down 20.93% from the prior year.
• Depreciation & Amortization (CF) climbed to $6.4 million in Q1 2026 per TWST's latest filing, from $6.2 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $8.5 million in Q3 2023 and bottomed at $4.0 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $6.6 million across 5 years, with a median of $6.4 million in 2025.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 103.7% — and 2025, when it fell 26.94%.
• Twist Bioscience's Depreciation & Amortization (CF) stood at $5.3 million in 2022, then jumped by 54.4% to $8.2 million in 2023, then declined by 21.92% to $6.4 million in 2024, then dropped by 2.92% to $6.2 million in 2025, then grew by 3.55% to $6.4 million in 2026.
• Business Quant data shows TWST's Depreciation & Amortization (CF) at $6.4 million in Q1 2026, $6.2 million in Q4 2025, and $6.0 million in Q3 2025.